Voorbeelden van het gebruik van Patients see section in het Engels en hun vertalingen in het Nederlands
{-}
-
Medicine
-
Colloquial
-
Official
-
Ecclesiastic
-
Financial
-
Computer
-
Ecclesiastic
-
Official/political
-
Programming
There is limited experience in paediatric patients, see section 4.8.
should not be used in these patients see section 4.3.
Optimark is contraindicated in these patients see section 4.3.
may lead to increases in serum potassium in hypertensive patients see section 4.5.
Kaletra should not be given to these patients see section 4.3.
In clinical studies, infections have been reported in a higher proportion of paediatric patients compared to adult patients see section 4.8.
Tolvaptan is contraindicated in anuric patients see section 4.3.
riociguat is contraindicated in these patients see section 4.3.
No dose adjustment is needed for elderly patients see section 4.4.
therefore use of Adempas is contraindicated in these patients see section 4.3.
Severe OHSS was reported in less than 0.5% of patients see section 4.4.
for paediatric patients and that previously reported for adult patients see section 4.8.
Combivir is therefore contraindicated in these patients see section 4.4.
is contraindicated in hypernatraemic patients see section 4.3.
Lopinavir/ritonavir must not be given to these patients see section 4.3.
tigecycline is not recommended for use in these patients see section 4.1.
Therefore use of Adempas is not recommended in these patients see section 4.4.
discontinue concurrent ITP medical therapies by the end of the study compared to 50% of placebo treated patients see section 4.5.
Serum potassium should be monitored closely in these patients see section 4.5.
because of limited clinical data available from studies including such patients see section 4.4 and section 5.2.
Therefore, Zalviso should be used with caution in such patients see section 4.4.
Stribild should be administered with caution to elderly patients see section 4.4.
Therefore, imiquimod cream should be used with caution in these patients see section 4.5.
Lamivudine/Zidovudine Teva is therefore contraindicated in these patients see section 4.4.
Therefore, caution should be used when prescribing naloxegol to such patients see section 4.3.
Therefore, caution is advised when administering Eurartesim to these patients see section 4.4.
Post-marketing, bone fractures have been reported in both male and female patients see section 4.4.
The most serious adverse event was meningococcal septicaemia in two vaccinated PNH patients see section 4.4.
Levels above 10 times the normal upper range occurred in 0.4%{PRODUCT NAME}-treated patients see section 4.4.
No specific dose adjustments are recommended based on the age of the patient see section 4.8.